| A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses G Prado-Vázquez, A Gámez-Pozo, L Trilla-Fuertes, JM Arevalillo, ... Scientific reports 9 (1), 1538, 2019 | 80 | 2019 |
| Functional proteomics outlines the complexity of breast cancer molecular subtypes A Gámez-Pozo, L Trilla-Fuertes, J Berges-Soria, N Selevsek, ... Scientific Reports 7 (1), 10100, 2017 | 54 | 2017 |
| Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics A Gámez-Pozo, L Trilla-Fuertes, G Prado-Vázquez, C Chiva, ... PLoS One 12 (6), e0178296, 2017 | 33 | 2017 |
| Urothelial cancer proteomics provides both prognostic and functional information G de Velasco, L Trilla-Fuertes, A Gamez-Pozo, M Urbanowicz, ... Scientific Reports 7 (1), 15819, 2017 | 26 | 2017 |
| Molecular characterization of breast cancer cell response to metabolic drugs L Trilla-Fuertes, A Gámez-Pozo, JM Arevalillo, M Díaz-Almirón, ... Oncotarget 9 (11), 9645, 2018 | 24 | 2018 |
| Isotopologue multipoint calibration for proteomics biomarker quantification in clinical practice C Chiva, O Pastor, L Trilla-Fuertes, A Gamez-Pozo, JA Fresno Vara, ... Analytical Chemistry 91 (8), 4934-4938, 2019 | 23 | 2019 |
| Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities L Trilla-Fuertes, A Gámez-Pozo, G Prado-Vázquez, A Zapater-Moros, ... BMC cancer 19, 1-9, 2019 | 19 | 2019 |
| Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer L Trilla-Fuertes, A Gámez-Pozo, E López-Camacho, G Prado-Vázquez, ... BMC cancer 20, 1-11, 2020 | 18 | 2020 |
| Immune expression profile identification in a group of proliferative verrucous leukoplakia patients: A pre-cancer niche for oral squamous cell carcinoma development C Llorens, B Soriano, L Trilla-Fuertes, L Bagan, R Ramos-Ruiz, ... Clinical Oral Investigations 25, 2645-2657, 2021 | 17 | 2021 |
| Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy S Alcalá, L Villarino, L Ruiz-Cañas, JR Couceiro, M Martínez-Calvo, ... Journal of Experimental & Clinical Cancer Research 43 (1), 33, 2024 | 16 | 2024 |
| Synergistic effect of antimetabolic and chemotherapy drugs in triple-negative breast cancer E López-Camacho, L Trilla-Fuertes, A Gámez-Pozo, I Dapía, ... Biomedicine & Pharmacotherapy 149, 112844, 2022 | 14 | 2022 |
| Melanoma proteomics suggests functional differences related to mutational status L Trilla-Fuertes, A Gámez-Pozo, G Prado-Vázquez, A Zapater-Moros, ... Scientific reports 9 (1), 7217, 2019 | 13 | 2019 |
| Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancer A Zapater-Moros, A Gámez-Pozo, G Prado-Vázquez, L Trilla-Fuertes, ... Oncotarget 9 (45), 27586, 2018 | 12 | 2018 |
| Comprehensive characterization of the mutational landscape in localized anal squamous cell carcinoma L Trilla-Fuertes, I Ghanem, J Maurel, G Laura, M Mendiola, C Peña, ... Translational Oncology 13 (7), 100778, 2020 | 11 | 2020 |
| Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer K Rojas, L Trilla-Fuertes, A Gámez-Pozo, C Chiva, J Sepúlveda, L Manso, ... ecancermedicalscience 13, 891, 2019 | 10 | 2019 |
| Protein content of blood-derived extracellular vesicles: An approach to the pathophysiology of cerebral hemorrhage F Laso-García, D Piniella, MC Gómez-de Frutos, L Casado-Fernández, ... Frontiers in Cellular Neuroscience 16, 1058546, 2023 | 9 | 2023 |
| MiRNAs in renal cell carcinoma J Miranda-Poma, L Trilla-Fuertes, E López-Camacho, A Zapater-Moros, ... Clinical and Translational Oncology 24 (11), 2055-2063, 2022 | 9 | 2022 |
| Identification of carcinogenesis and tumor progression processes in pancreatic ductal adenocarcinoma using high-throughput proteomics L Trilla-Fuertes, A Gámez-Pozo, MI Lumbreras-Herrera, R López-Vacas, ... Cancers 14 (10), 2414, 2022 | 8 | 2022 |
| miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma L Trilla-Fuertes, N Miranda, D Castellano, R López-Vacas, ... PloS one 15 (2), e0229075, 2020 | 8 | 2020 |
| Bayesian networks established functional differences between breast cancer subtypes L Trilla-Fuertes, A Gámez-Pozo, JM Arevalillo, R López-Vacas, ... PloS one 15 (6), e0234752, 2020 | 7 | 2020 |
